chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Eye pruritus, Migraine, Rhinorrhoea
Clinical narrative: Runny nose; Itchy eyes; Migraines; Joint Pain; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 09:30 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to seasame seed and wheat, COVID-19. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) from an unknown date for an unspecified indication. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 10:00, the patient experienced runny nose, itchy eyes, migraines, joint pain. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events runny nose, itchy eyes, migraines, joint pain was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus has become very loud.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 19Mar2021(at the age of 59-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 09Apr2021 as a single dose for COVID-19 immunisation. Medical history included blood pressure high and cholesterol high. Concomitant medications included lisinopril dihydrate (LISINOPRIL) and pravastatin (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 the patient experienced tinnitus that had become very loud. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event tinnitus has become very loud was not recovered at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Rash
Clinical narrative: Rash developed next day. Rash spread from arm to rest of body.; Lightheaded and dizziness.; Lightheaded and dizziness.; This is a spontaneous report from a contactable healthcare professional. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via intramuscular route of administration in the left arm on 06Apr2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, depression, hypercholesteremia. The patient previously took penicillin and experienced penicillin allergy. The patient previously took Bactrim and Levaquin and experienced drug allergy to Bactrim and Levaquin. Concomitant medications taken within two weeks of vaccination included atorvastatin (MANUFACTURER UNKNOWN), nebivolol hydrochloride (BYSTOLIC), bupropion (MANUFACTURER UNKNOWN), paracetamol (ACETAMINOPHEN) and loratadine (CLARITIN) all from unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via intramuscular route of administration in the left arm on 18Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced lightheaded and dizziness. Rash developed next day on 07Apr2021. Rash spread from arm to rest of body. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of lightheaded, dizziness and rash and included treatment with Hydroxyzine. The clinical outcome of the events lightheaded and dizziness, rash developed next day and rash spread from arm to rest of body was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Syncope
Clinical narrative: Vasovagal syncope followed by metallic/bleach taste in mouth; Vasovagal syncope followed by metallic/bleach taste in mouth; This is a spontaneous report from a non-contactable consumer.  A non-pregnant 36-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 06Apr2021 09:45 (Batch/Lot Number: Unknown) as dose 1, single (at the age of 36 years old) for COVID-19 immunisation.  Medical history included allergies: Penicillin and NSAIDs. Concomitant medications included ascorbic acid, biotin, calcium carbonate, calcium pantothenate, chromium nicotinate, colecalciferol, cupric oxide, cyanocobalamin, ferrous fumarate, folic acid, magnesium hydroxide, manganese gluconate, nicotinamide, phytomenadione, potassium iodide, pyridoxine hydrochloride, retinol, riboflavin, selenomethionine, sodium molybdate, thiamine hydrochloride, tocopheryl acetate, zinc gluconate (MULTIVITAMIN FOR WOMEN) taken for an unspecified indication, start and stop date were not reported.  The patient experienced vasovagal syncope followed by metallic/bleach taste in mouth on 06Apr2021 10:00. The event required doctor or other healthcare professional office/clinic visit. The patient received no treatment. The outcome of events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This is a spontaneous report from a contactable consumer (patient) via medical information team. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that the Pfizer product was fine "Saturday" and had fever on an unknown date and "today" (12Apr2021) patient was normal. The patient wanted to know how long it will last, referring to the efficacy of the Pfizer vaccine, so we will need to get a 3rd dose in 6 months and what will happen if we get a 3rd dose. The outcome of the event was reported as resolved on 12Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Lung disorder, Pain, Pyrexia
Clinical narrative: high temperature/fever up and down; lungs shutting down; could not breathe; body aches; chest keeps hurting; This is a spontaneous report from a contactable consumer or other non hcp (parent) from a Pfizer sponsored program. A 27-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included autism. Concomitant medications were not reported. The reporter stated that the patient received the first dose of the Pfizer COVID vaccine on 09Apr2021 and has been having a fever up and down and body aches. Caller states she has taken her to the doctor and the doctor prescribed promethazine with codeine and prednisone. Caller states her daughter has also been complaining that her chest keeps hurting and the doctor prescribed albuterol with budesonide. Caller states she has been giving her Tylenol for the fever and it has been 72 hours and it still has not gone away. The patient began running high temperature, lungs shutting down and could not breathe caller contacted pulmonologist who gave albuterol, steroids, daughter is still having breathing issues. Caller states she has an appointment with the doctor tomorrow who will be making the decision as to whether or not she will be getting the second dose. Caller asked what if her daughter does not receive the second dose how will this affect her being able to travel and what will the vaccination site put on her vaccination card when she goes back on 07May2021 for second dose even if her daughter does not receive hers. Caller would like to know if she is exempted from the 2nd dose, can she still travel. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Painful joints all over my body, especially hands, shoulders, upper back, ankles, knees; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 26Mar2021 at 09:00 (at the age of 66-years-old) as single dose for COVID-19 immunisation. Medical history included hypertension, thyroid disorder, GERD and cholesterol. The patient was allergic to penicillin, sulfa drugs and codeine (MANUFACTURER UNKNOWN). Concomitant medications included diltiazem (MANUFACTURER UNKNOWN), valsartan (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN); all from an unknown date and for unknown indications. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 05Apr2021, the patient experienced painful joints all over her body, especially hands, shoulders, upper back, ankles and knees. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the event painful joints all over my body, especially hands, shoulders, upper back, ankles and knees were unknown at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Chills, Intermenstrual bleeding, Lymphadenopathy
Clinical narrative: Breast pain; Menstrual spotting, This is not the normal time of the month for my female cycle to begin.; Menstrual spotting, This is not the normal time of the month for my female cycle to begin.; Fever; Chills; Body aches; Pain in left underarm area; Swollen lymph node in left underarm; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 23Mar2021 at 15:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ); both from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 02Mar2021 at 15:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation and took AUGMENTIN and SEPTRA; both on an unknown date for an unspecified indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 18:30 the patient experienced pain in left underarm area and swollen lymph node in left underarm beginning day of shot. Symptoms lasted about a week. On 24Mar2021, the day following shot, the patient experienced Fever, chills and body aches and continued for about 36 hours. On an unknown date in Apr2021 the patient experienced Breast pain began about two weeks following shot and menstrual spotting began approximately 2-3 days after breast pain began. This is not the normal time of the month for my female cycle to begin. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the pain in left underarm area and swollen lymph node in left underarm was resolved on unknown date and of the fever, chills and body aches was resolved on unknown date in Mar2021 and of the breast pain, menstrual spotting and irregular period was not resolved, at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular, Pain, Pyrexia
Clinical narrative: Breast pain; Menstrual spotting, This is not the normal time of the month for my female cycle to begin.; Menstrual spotting, This is not the normal time of the month for my female cycle to begin.; Fever; Chills; Body aches; Pain in left underarm area; Swollen lymph node in left underarm; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 23Mar2021 at 15:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ); both from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 02Mar2021 at 15:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation and took AUGMENTIN and SEPTRA; both on an unknown date for an unspecified indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 at 18:30 the patient experienced pain in left underarm area and swollen lymph node in left underarm beginning day of shot. Symptoms lasted about a week. On 24Mar2021, the day following shot, the patient experienced Fever, chills and body aches and continued for about 36 hours. On an unknown date in Apr2021 the patient experienced Breast pain began about two weeks following shot and menstrual spotting began approximately 2-3 days after breast pain began. This is not the normal time of the month for my female cycle to begin. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the pain in left underarm area and swollen lymph node in left underarm was resolved on unknown date and of the fever, chills and body aches was resolved on unknown date in Mar2021 and of the breast pain, menstrual spotting and irregular period was not resolved, at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the a left arm on 29Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medications. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6206) via an unspecified route of administration in the left arm on 08Mar2021 at 17:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 09:00, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with anti viral medication and pain medication. The clinical outcome of the event shingles was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea, SARS-CoV-2 test
Clinical narrative: Nausea; Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer. An adult male patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in 2021, the patient had his second vaccine. The patient was experiencing nausea, diarrhea and fatigue. He had been to doctor and tested for COVID. The patient indicated that same thing had happened on his first dose. The adverse events resulted in doctor or other healthcare professional office/clinic visit.  The patient underwent covid test on an unknown date in Apr2021 and the test result was pending. Therapeutic measures were taken as a result of the events nausea, diarrhea and fatigue. The clinical outcome of the events nausea, diarrhea and fatigue were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Electrocardiogram, Headache, Migraine, Panic reaction
Clinical narrative: sudden pain in my chest that quickly intensified; painful sinus infection feeling; migraine for 3 days with a lingering headache for 2 more days; migraine for 3 days with a lingering headache for 2 more days; I was then in panic mode; This is a spontaneous report from a contactable consumer (Patient). A 58-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in Arm Right on 17Feb2021 14:15 (at the age of 58-years old) as dose 1, single for Covid-19 immunization. Medical history included none. Concomitant medications received within 2 weeks of vaccination included topiramate (TOPIRAMATE), ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication, start and stop date were not reported. The patient previously took motrin [IBUPROFEN] and experienced allergies. Prior to vaccination, patient was not diagnosed with Covid-19. Patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. On 17Feb2021 14:15, the patient stated 24 hours after first dose she was teaching online and got a sudden pain in her chest that quickly intensified. She was in severe pain and had her husband take him to the EMT station a few doors down from her home. The pain began to radiate down her sides and into her stomach. The EMT did an EKG and determined it was not a heart attack and helped her calm down. She was then in panic mode. The chest pains lasted the rest of the night off and on but less intense. She also had a painful sinus infection feeling/migraine for 3 days with a lingering headache for 2 more days. Treatment received with Imetrix, lots of fluids and lots of sleep. Since the vaccination, patient has not been tested for Covid-19. The patient underwent lab tests and procedures which included electrocardiogram: not a heart attack on 17Feb2021- The EMT did an EKG and determined it was not a heart attack and helped me calm down. Outcome of events was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: sudden pain in my chest that quickly intensified; painful sinus infection feeling; migraine for 3 days with a lingering headache for 2 more days; migraine for 3 days with a lingering headache for 2 more days; I was then in panic mode; This is a spontaneous report from a contactable consumer (Patient). A 58-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in Arm Right on 17Feb2021 14:15 (at the age of 58-years old) as dose 1, single for Covid-19 immunization. Medical history included none. Concomitant medications received within 2 weeks of vaccination included topiramate (TOPIRAMATE), ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication, start and stop date were not reported. The patient previously took motrin [IBUPROFEN] and experienced allergies. Prior to vaccination, patient was not diagnosed with Covid-19. Patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. On 17Feb2021 14:15, the patient stated 24 hours after first dose she was teaching online and got a sudden pain in her chest that quickly intensified. She was in severe pain and had her husband take him to the EMT station a few doors down from her home. The pain began to radiate down her sides and into her stomach. The EMT did an EKG and determined it was not a heart attack and helped her calm down. She was then in panic mode. The chest pains lasted the rest of the night off and on but less intense. She also had a painful sinus infection feeling/migraine for 3 days with a lingering headache for 2 more days. Treatment received with Imetrix, lots of fluids and lots of sleep. Since the vaccination, patient has not been tested for Covid-19. The patient underwent lab tests and procedures which included electrocardiogram: not a heart attack on 17Feb2021- The EMT did an EKG and determined it was not a heart attack and helped me calm down. Outcome of events was resolved on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Skin discolouration
Clinical narrative: The morning after my vaccination my right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go.; The morning after my vaccination my right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go.; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications included calcium carbonate, magnesium carbonate (TUMS) and acetylsalicylic acid, ascorbic acid (ASPIRIN), all for unknown indication from an unknown date. Allergies to medications, food, or other products was reported as unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 06:00, the morning after the vaccination patient's right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events right thumb turned purple/black from the joint to the tip along with feelings of pins and needles that come and go was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Muscle spasms, Pain, Pain in extremity
Clinical narrative: Could hardly get up and dress herself; Was aching too bad to go to dialysis this morning; right arm feeling numb; muscle spasms; Right arm severe pain; up into shoulder and neck; This is spontaneous report received from contactable female consumer (patient). A 56-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 10Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included dialysis from on an unspecified date in Sep2019 and ongoing, High Blood Pressure from on an unspecified date in 1999 and ongoing, Severe Pains and Arthritis from on an unspecified date in 2010 and ongoing. Concomitant medication included irbesartan taken for blood pressure measurement, amlodipine taken for blood pressure measurement from an unspecified start date and ongoing; oxycodone hydrochloride, oxycodone terephthalate, paracetamol (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) taken for pain from an unspecified start date and ongoing (Stated Percocet; then spelled Oxycodone Acetaminophen from bottle); cefixime (FLEXERIL [CEFIXIME]) taken for pain from an unspecified start date and ongoing. The patient stated that, she received her first dose of the Pfizer BioNTech COVID-19 vaccine on 10Mar2021 at dialysis and states on 9Apr2021 she started experiencing her right arm feeling numb, muscle spasms, and severe in her right arm and shoulder going towards her neck. Caller would like to know if it is normal to experience these side effects this far out from the vaccine. The patient got first dose on 10Mar2021 and has not gotten second one yet. The patient experienced right arm feeling numb, muscle spasms and right arm severe pain; up into shoulder and neck on 09Apr2021 and was aching too bad to go to dialysis this morning on 12Apr2021 and could hardly get up and dress herself on an unspecified date. Outcome of the events right arm feeling numb, muscle spasms and Right arm severe pain; up into shoulder and neck was not recovered and outcome of the other events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Palpitations, Vaccination site pain
Clinical narrative: Initially, I had pain at the injection site which I expected.; But, since for the past couple of days I I have had heart palpitations off and on; My chest feels tight.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 11:15 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), multivitamin and probiotic, all used for unknown indication from unspecified dates and unknown if ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 20:00, the patient experienced pain at the injection site which she expected. Since past couple of days, she had heart palpitations off and on and her chest felt tight. Therapeutic measures were not taken as a result of these events. These events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site pain,  heart palpitations  and  chest tightness was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Pain in extremity
Clinical narrative: Sore Left Arm; Pain at the lower right abdominal; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 08Apr2021 at 16:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included fibroids. The patient was allergic to amoxicillin. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 16:00, the patient experienced pain at the lower right abdominal and at 17:15 she experienced sore left arm. The patient also reported that she never had any pain or discomfort at the right abdominal area even though she had fibroid not after she took the 1st dose Pfizer vaccine. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events sore left arm and pain at the lower right abdominal was not resolved.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Dizziness, Pain, Vertigo
Clinical narrative: Extreme vertigo; Extreme body aches; dizziness; other common side effects; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 17:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included Chronic Obstructive Pulmonary Disease (COPD), bronchitis and gastritis. Concomitant medications included clonazepam (MANUFACTURER UNKNOWN), citalopram (MANUFACTURER UNKNOWN), pantoprazole sodium sesquihydrate (PROTONIX), sucralfate (CARAFATE) and buspirone hydrochloride (BUSPAR), all taken for unspecified indications from unknown dates. The patient previously took biaxin and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 17:00, the patient experienced extreme body aches, dizziness and other common side effects. On 12Apr2021, 5 days later, the patient had to leave work due to extreme dizziness and vertigo. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme body aches, dizziness, other common side effects and vertigo were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Myalgia
Clinical narrative: Had muscle pain through the left side of neck extending to clavicle on left side and back to scapula on left side; Swollen lymph nodes on left side of neck; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 16:15 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had no known allergies to medications, food or other products. On 28Mar2021 at 07:00, since the day following vaccination, the patient had muscle pain through the left side of neck extending to clavicle on left side and back to scapula on left side and also had swollen lymph nodes on left side of neck. The patient was reporting pain that started 2 weeks ago. The patient has never had pain that lasted as long as this had. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the events had muscle pain through the left side of neck extending to clavicle on left side and back to scapula on left side and swollen lymph nodes on left side of neck was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Lymphadenopathy
Clinical narrative: Swollen Lymph nodes in left arm pit; Swollen Lymph nodes in left arm pit along with a lump; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 17Mar2021 at 15:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient has not reported any other health issues. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient did not have a history of allergies to medications, food or other products. Concomitant medications were not reported. On 04Apr2021 at 05:00, the patient experienced swollen lymph nodes in left armpit along with a lump. It was unknown whether any therapeutic measures were taken as a result of the event. The event resulted in doctor or other healthcare professional office/clinic visit. Prior to the vaccination, the patient was not diagnosed with COVID-19. The clinical outcome of the event swollen lymph nodes in left armpit along with a lump was not recovered at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 12:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Neck pain, Pain in extremity, Paraesthesia, Urticaria
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 43-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0151), at the age of 43, via an unspecified route of administration, left arm, on Apr 8, 2021, at 19:30, single dose, for COVID-19 immunisation. The patient did not have other medical history. The patient has no known allergies to medications, food or other products. The patient took other medication within two weeks of vaccination, which included vitamins (unspecified).  Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced a number of side effects since taking the vaccine. On Apr 9, 2021 at 15:30, initially it was just her arm that was very sore and stiffness in her neck. Approximately 24 hours after the vaccination, on Apr 9, 2021, she  broke out in hives on her chest. Following the hives, patient experienced a pins and needles sensation in various places throughout her body from an unknown date in Apr 2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. The outcome of the sore arm and hives on chest resolved at the time of report on Apr 12, 2021; while pins and needle sensation still ongoing. Patient's periodic stiffness/pain in neck: not resolved at the time of report. No follow-up attempts needed. No further information expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Bacterial infection, Bronchitis, Cough, Fatigue, Illness
Clinical narrative: Got sick after the vaccine,; I received it Tuesday afternoon and the next day I woke up with an extremely sore throat.; Also had other normal vaccine side effects like feeling run down and tired.; Congested cough; Bronchitis; Nasal congestion; Runny nose; Bacterial infection; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date in Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, laryngopharyngeal reflux, COVID-19, allergy (unspecified), allergy to nuts, allergy to pea and seasonal allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC), omeprazole (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), fluticasone propionate (FLOVENT) and fish oil (MANUFACTURER UNKNOWN); all for unknown indications and since unknown dates. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, the patient got sick after the vaccine, she received it Tuesday afternoon and the next day she woke up with an extremely sore throat. Also had other normal vaccine side effects like feeling run down and tired. The sore throat devolved into a congested cough which turned into bronchitis and also had nasal congestion and runny nose. Went to the doctor on Sunday as she had 3 straight days of not got better and was diagnosed with a bacterial infection and put on a Z pack and prednisone. On an unknown date in Apr2021 (Monday, 6 days after getting vaccine), she developed a low-grade fever which went away in a few hours. At the time of this report, she had a cough and congestion but it was started to get better with the antibiotics. The events sick, sore throat, feeling run down and tired, congested cough, bronchitis, nasal congestion, runny nose, bacterial infection resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with z-pack and prednisone. The clinical outcome of the events low grade fever was recovered on an unknown date of Apr2021.The clinical outcome of the events sick, sore throat, feeling run down and tired, congested cough, bronchitis, nasal congestion, runny nose, and bacterial infection was recovering at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Oropharyngeal pain, Pyrexia, Rhinorrhoea
Clinical narrative: Got sick after the vaccine,; I received it Tuesday afternoon and the next day I woke up with an extremely sore throat.; Also had other normal vaccine side effects like feeling run down and tired.; Congested cough; Bronchitis; Nasal congestion; Runny nose; Bacterial infection; Low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date in Apr2021 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, laryngopharyngeal reflux, COVID-19, allergy (unspecified), allergy to nuts, allergy to pea and seasonal allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC), omeprazole (MANUFACTURER UNKNOWN), montelukast sodium (SINGULAIR), fluticasone propionate (FLOVENT) and fish oil (MANUFACTURER UNKNOWN); all for unknown indications and since unknown dates. Prior to the vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021, the patient got sick after the vaccine, she received it Tuesday afternoon and the next day she woke up with an extremely sore throat. Also had other normal vaccine side effects like feeling run down and tired. The sore throat devolved into a congested cough which turned into bronchitis and also had nasal congestion and runny nose. Went to the doctor on Sunday as she had 3 straight days of not got better and was diagnosed with a bacterial infection and put on a Z pack and prednisone. On an unknown date in Apr2021 (Monday, 6 days after getting vaccine), she developed a low-grade fever which went away in a few hours. At the time of this report, she had a cough and congestion but it was started to get better with the antibiotics. The events sick, sore throat, feeling run down and tired, congested cough, bronchitis, nasal congestion, runny nose, bacterial infection resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with z-pack and prednisone. The clinical outcome of the events low grade fever was recovered on an unknown date of Apr2021.The clinical outcome of the events sick, sore throat, feeling run down and tired, congested cough, bronchitis, nasal congestion, runny nose, and bacterial infection was recovering at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Severe swelling on face on same side as vaccine; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Apr2021 at 10:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa from an unknown date. Concomitant medications included fluoxetine hydrochloride (PROZAC), bupropion hydrochloride (WELLBUTRIN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and buprenorphine hydrochloride (SUBUTEX); all were taken for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 08:15 (also reported as at 14:00), 46 hours after receiving the vaccine, the patient experienced severe swelling on face on same side as vaccine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event severe swelling on face on same side as vaccine was recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Muscle spasms, Pain, Vomiting
Clinical narrative: Severe body pain; Severe body cramps; Headache; Chills; Vomiting; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the arm left on 10Apr2021 at 15:00(at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included adhd (Attention deficit hyperactivity disorder).The patient did not have any allergies to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) from an unknown date for unknown indication taken within 2 weeks of vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 15:00(at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 11Apr2021 at 10:00 the patient experienced Severe body pains/cramps, headache, chills and vomiting. No therapeutic measures were taken as a result of the events. The clinical outcome of the events Severe body pains/cramps, headache, chills and vomiting were recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.